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Abstract 20 
The physiological and exercise performance adaptations to sprint interval training (SIT) may 21 
be modified by dietary nitrate (NO3-) supplementation. However, it is possible that different 22 
types of NO3- supplementation evoke divergent physiological and performance adaptations to 23 
SIT. The purpose of this study was to compare the effects of 4 weeks SIT with and without 24 
concurrent dietary NO3- supplementation administered as either NO3--rich beetroot juice (BR) 25 
or potassium NO3- (KNO3). Thirty recreationally-active subjects completed a battery of 26 
exercise tests before and after a 4 week intervention in which they were allocated to one of 27 
three groups: 1) SIT undertaken without dietary NO3- supplementation (SIT); 2) SIT 28 
accompanied by concurrent BR supplementation (SIT+BR); or 3) SIT accompanied by 29 
concurrent KNO3 supplementation (SIT+KNO3). During severe-intensity exercise, V̇O2peak and 30 
time to task failure were improved to a greater extent with SIT+BR than SIT and SIT+KNO3 31 
(P<0.05). There was also a greater reduction in the accumulation of muscle lactate at 3-min of 32 
severe-intensity exercise in SIT+BR compared to SIT+KNO3 (P<0.05). Plasma [NO2-] fell to 33 
a greater extent during severe-intensity exercise in SIT+BR compared to SIT and SIT+KNO3 34 
(P<0.05). There were no differences between groups in the reduction in the muscle 35 
phosphocreatine recovery time constant from pre- to post-intervention (P>0.05). These 36 
findings indicate that 4 weeks SIT with concurrent BR supplementation results in greater 37 
exercise capacity adaptations compared to SIT alone and SIT with concurrent KNO3 38 
supplementation. This may be the result of greater NO-mediated signalling in SIT+BR 39 
compared to SIT+KNO3.  40 
Keywords: nitric oxide; fitness; diet; endurance; ergogenic aid; nutrition. 41 
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New and Noteworthy: We compared the influence of different forms of dietary nitrate 43 
supplementation on the physiological and performance adaptations to sprint interval training 44 
(SIT). Compared to SIT alone, supplementation with nitrate-rich beetroot juice, but not KNO3, 45 
enhanced some physiological adaptations to training. 46 
 47 
 48 
  49 
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Introduction 50 
Over the last decade, dietary supplementation with inorganic nitrate (NO3-) has emerged as a 51 
popular pre-competition nutrition strategy to enhance athletic performance. This practice 52 
originates from evidence that dietary NO3- supplementation can enhance a range of 53 
physiological processes, including skeletal muscle metabolic (2, 35, 62), contractile (11, 28, 54 
29, 66) and vascular function (16, 17) with attendant implications for improved performance 55 
in a range of exercise settings (5, 33, 58, 60, 69).  56 
Favourable effects on resting blood pressure (BP) have been observed following NO3- ingested 57 
in the form of both NO3--rich beetroot juice (BR; 31, 64) and NO3- salts (KNO3 or NaNO3; 1, 58 
32, 34). However, some recent studies suggest that BR/NO3--rich vegetables and NO3- salts can 59 
evoke disparate physiological effects (18, 30). The improvement in some physiological 60 
responses in the contracting skeletal muscle following NO3- supplementation has been 61 
attributed to enhanced nitroso signalling facilitated by elevated nitrite (NO2-), s-nitrosothiol 62 
and/or NO bioavailability (40, 57, 64). Importantly, the co-ingestion of the betacyanins and 63 
polyphenols found in BR may increase the capacity for NO synthesis from NO2- (21, 50). 64 
Moreover, chlorogenic acid, a constituent of BR, has been shown to promote NO release by 65 
human saliva at the acidic pH of the stomach (50). Therefore, ingesting NO3- as BR, which is 66 
accompanied by the co-ingestion of compounds that might facilitate the NO3-- NO2- -NO 67 
pathway, has the potential to enhance NO-mediated physiological signalling compared to a 68 
similar dose of NO3- administered as NO3- salts.   69 
In addition to enhanced physiological and performance responses following NO3- 70 
supplementation in an acute exercise setting, recent evidence suggest that NO3- 71 
supplementation in the form of BR (59), a high NO3- gel (44) or NaNO3 (14) can modulate 72 
some of the physiological and performance adaptations to sprint interval training (SIT).  73 
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Increased exposure to NO3- or NO2- has been reported to activate PGC1-α (51) and AMPK (42) 74 
which initiate signalling cascades that promote adaptive skeletal muscle remodelling to 75 
exercise (23). However, while consumption of BR or NO3--rich vegetables can lower the O2 76 
cost of submaximal exercise (18) and BP (30) compared to an equivalent dose of NaNO3, it 77 
has yet to be determined whether equimolar doses of inorganic NO3- administered through 78 
different supplementation vehicles elicit comparable or divergent physiological and 79 
performance adaptations to an exercise training program.   80 
As well as serving as an NO precursor, BR contains a number of compounds with antioxidant 81 
properties (55, 67). The most abundant betacyanin present in BR, betanin, has been shown to 82 
possess high antioxidant activity (9). There is some evidence to suggest that supplementation 83 
with antioxidant compounds during an exercise training program can blunt some of the skeletal 84 
muscle adaptive responses to exercise training (26, 43, 48). It has been reported that BR 85 
contains a high total antioxidant capacity relative to other vegetable juices (67), although this   86 
would be substantially lower than in training studies reporting compromised training 87 
adaptations in which high doses of vitamin C (1 g) and vitamin E (up to 294 mg) were 88 
administered (43, 48). Therefore, while BR has the potential to augment NO-mediated 89 
signalling, and by extension the activation of transcription pathways integral to muscle 90 
remodelling to exercise, it remains possible that this benefit might be offset by the antioxidant 91 
effects of BR supplementation and the potential suppression of exercise-evoked adaptive 92 
signalling cascades.  Therefore, further research is required to address the influence of the NO3- 93 
administration vehicle on the adaptations to an exercise training program.   94 
The purpose of this study was to compare the physiological and exercise performance 95 
adaptations to 4 weeks SIT accompanied by concurrent supplementation with BR (SIT+BR) 96 
or potassium NO3- (KNO3) (SIT+KNO3) or SIT undertaken without dietary NO3- 97 
supplementation (SIT). It was hypothesised that exercise performance, muscle oxidative 98 
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capacity measured in vivo using 31phosphorus magnetic resonance spectroscopy (31P-MRS), 99 
and muscle metabolic adaptions measured from muscle biopsy samples would be improved 100 
following all SIT interventions, but that these variables would be improved more in the 101 
SIT+BR group compared to the SIT+KNO3 and SIT groups due to enhanced NO-mediated 102 
physiological signalling in SIT+BR. 103 
Methods 104 
Subjects 105 
Eighteen male (mean ± SD: age 25 ± 6 years, height 1.82 ± 0.07 m, body mass 85 ± 12 kg, 106 
V̇O2peak 46.6 ± 7.5 mL·kg-1·min-1) and 12 female (mean ± SD: age 22 ± 3 years, height 1.71 ± 107 
0.08 m, body mass 66 ± 10 kg, V̇O2 peak 39.9 ± 3.9 mL·kg-1·min-1) volunteers were recruited. 108 
The subjects were involved in team and/or endurance sports but were not highly trained. 109 
Following an explanation of the experimental procedures, associated risks, potential benefits 110 
and likely value of the possible findings, subjects gave their written informed consent to 111 
participate. The study was approved by the Institutional Research Ethics Committee and 112 
conformed to the code of ethics of the Declaration of Helsinki. 113 
Experimental design  114 
Subjects initially visited the laboratory on 3 separate occasions over a 5 day period. On visit 1, 115 
subjects completed an incremental exercise test on a cycle ergometer for the determination of 116 
V̇O2peak and gas exchange threshold (GET). The work rates requiring 80% of the GET (moderate 117 
exercise) and 85%∆ (GET plus 85% of the difference between the work rate at GET and 118 
V̇O2peak; severe exercise) were calculated and adjusted for mean response time for V̇O2 during 119 
incremental exercise (65). Following this, subjects were familiarized to the exercise testing 120 
procedures, including completion of a severe-intensity bout of cycle ergometry until 121 
exhaustion. On visit 2, subjects completed the 31P-MRS protocol (see below) before a 5-min 122 
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bout of moderate-intensity cycling and an incremental exercise test were performed. On visit 123 
3, subjects completed 2 bouts of severe-intensity cycling, the first for 3-min and the second 124 
until task failure.  125 
A third party (not associated with data collection and analysis) received the baseline 126 
characteristics of each participant before assigning participants, in a group characteristic 127 
matched manner, to one of three SIT groups. Thereafter, in a double-blind, independent-groups 128 
design, subjects were enrolled onto a 4-week supervised SIT program and assigned to receive 129 
either NO3- rich BR (SIT+BR; age 25 ± 7 years, height 1.76 ± 0.11 m, body mass 80 ± 19 kg), 130 
KNO3- (SIT+KNO3: age 25 ± 3 years, height 1.76 ± 0.09 m, body mass 75 ± 13 kg) or water 131 
(SIT: age 22 ± 3 years, height 1.79 ± 0.08 m, body mass 78 ± 12 kg) for 28 days. The SIT+BR 132 
and SIT+KNO3 groups were deliberately misinformed that they might be consuming 133 
supplements that were either active (NO3--rich) or placebo alternatives. All three groups 134 
consisted of 6 male and 4 female subjects. Each group consumed 1 x 70 mL of their allocated 135 
supplements (SIT+BR; ~6.4 mmol of NO3- per 70 mL; Beet it, James White Drinks Ltd., 136 
Ipswich, UK; SIT+KNO3: ~6.4 mmol of NO3- per 70 mL; Minerals-Water.ltd, Purfleet, UK) 137 
in the morning and 1 x 70 mL in the evening of each day for the duration of the training period. 138 
This approach is expected to result in elevated plasma [NO3-] and [NO2-] for each 24 h period 139 
(68).  On experimental visits following the intervention period, subjects consumed 2 x 70 mL of 140 
their allocated supplement 2.5 h prior to the exercise tests. Compliance to the supplementation 141 
procedures was confirmed by the return of empty bottles each week and via the completion of 142 
questionnaires during and following the intervention period.  143 
All groups completed the same exercise tests (at the same absolute work rates) and 144 
physiological assessments both before and after the 28-day intervention period. Laboratory 145 
visits were scheduled at the same time of day (± 2 h). Subjects were asked to maintain their 146 
8 
 
normal dietary and exercise behavior throughout the study. However, subjects were instructed 147 
to record their diet during the 24 h preceding the first laboratory visit and to repeat this for all 148 
subsequent laboratory visits. On training days, subjects were asked to arrive at the training 149 
venue ≥1 h post-prandial and to complete a 5 min self-paced warm up before training 150 
commenced. On experimental days, subjects were instructed to arrive at the laboratory ≥3 h 151 
post-prandial having avoided strenuous exercise and the consumption of alcohol and caffeine 152 
in the 24 h preceding each exercise test. For the duration of the study, subjects were asked to 153 
refrain from taking other dietary supplements and to avoid the use of antibacterial mouthwash 154 
as this inhibits the reduction of NO3- to NO2- in the oral cavity by eliminating commensal 155 
bacteria (27).  156 
Training intervention 157 
During the training sessions, all subjects completed a series of 30-s “all-out” sprints (i.e. 158 
Wingate test) against a resistance equivalent to 7.5% body mass on a mechanically-braked 159 
cycle ergometer (model 814E, Monark, Stockholm, Sweden). Each sprint was separated by a 160 
4-min period of rest in which subjects cycled at a low cadence against a light resistance to 161 
reduce venous pooling and sensations of nausea. During weeks 1 and 2 of training, subjects 162 
performed 4 x 30-s sprints three times per week, while during weeks 3 and 4, subjects 163 
performed 5 x 30-s sprints four times per week. Following a 5-min warm up of cycling against 164 
a light resistance, subjects were given a 10-s count down and instructed to pedal maximally for 165 
2 s before the appropriate load was applied. Subjects were verbally encouraged to maintain 166 
maximal cadence throughout each 30-s sprint. All groups completed a total of 14 supervised 167 
training sessions over a 4-week period, with at least 24 h separating each training session. The 168 
post-intervention laboratory tests were performed at least 48 h following, but within 4 days of 169 
the completion of the final training session. All subjects completed 100% of the training 170 
sessions and 100% of the sprints during the intervention. 171 
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Incremental exercise tests 172 
Subjects completed all ramp incremental exercise tests on an electronically braked cycle 173 
ergometer (Lode Excalibur Sport, Groningen, Netherlands). The self-selected cadence (75-90 174 
rpm), saddle and handle bar height and configuration for each subject were recorded on the 175 
first visit and reproduced in subsequent visits. Initially, subjects performed 3-min of baseline 176 
cycling at 20 W, after which the work rate was increased by 30 W/min until task failure. Breath-177 
by-breath pulmonary gas exchange data (Oxycon Pro, Jaeger, Hoechberg, Germany) were 178 
collected continuously throughout all incremental tests and were averaged over 10-s periods. 179 
V̇O2peak and GET were determined as previously described (61).  180 
Step exercise tests 181 
A 5-min moderate-intensity “step” test was performed on the first laboratory visit before and 182 
following the intervention. This was completed 10 min before the ramp incremental test 183 
protocol was initiated. On the second laboratory visit before and following the intervention, 184 
two severe-intensity step tests were performed, separated by a 20 min period of rest; the first 185 
until 3-min, and the second until task failure. The time to task failure was recorded once the 186 
pedal rate fell by >10 rpm below the target cadence. All step tests began with 3-min of pedaling 187 
at 20 W before a sudden transition to the target work rate. Muscle biopsies were obtained before 188 
and following the 3-min severe-intensity exercise bout and again at task failure in the second 189 
bout. Breath-by-breath pulmonary gas exchange data were collected continuously throughout 190 
all step tests. 191 
31P-MRS protocol 192 
Before the initial experimental visit, participants were familiarised to the 31P-MRS protocol 193 
using a custom-built, non-ferrous ergometer in the bore of a purpose built ‘mock’ magnetic 194 
resonance scanner. Before and following the intervention, subjects completed four bouts of 195 
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single-leg knee extension exercise (over a distance of ~0.22 m) in a prone position within the 196 
bore of a 1.5 T superconducting magnet (Gyroscan Clinical Intera, Philips, The Netherlands) 197 
using a custom-built, non-ferrous ergometer at the University of Exeter Magnetic Resonance 198 
Research Centre (Exeter, UK) as previously described (20, 62). Each 24-s bout of high-199 
intensity exercise (20 ± 4 W) was separated by 4 min. 31P-MRS was used for the assessment 200 
of muscle PCr recovery kinetics with data acquired every 1.5 s leading to a spectrum every 6 s 201 
via a four phase cycle protocol. Due to technical issues with the scanner at the start of data 202 
collection the subject number included in the analyses was restricted within each group to n = 203 
9. 204 
Measurements 205 
Blood pressure  206 
Before and following the intervention the BP at the brachial artery was measured using an 207 
automated sphygmomanometer (Dinamap Pro: GE Medical Systems, Tampa, FL). Following 208 
10 min seated rest in an isolated room, three measurements were recorded. The means of the 209 
systolic and diastolic measurements were used for data analysis.  210 
Blood analysis 211 
Venous blood was sampled at rest (baseline) before each experimental test. Blood samples 212 
were also obtained at 1-min, at 3-min and at exhaustion during the severe-intensity exercise 213 
bout. The blood samples collected during the severe-intensity exercise bout were drawn from 214 
a cannula (Insyte-WTM, Becton Dickinson, Madrid, Spain) inserted into the subject’s 215 
antecubital vein and were collected into lithium-heparin vacutainers (Becton Dickinson, New 216 
Jersey, USA). Blood [lactate] and [glucose], as well as plasma [NO2-] were analyzed in all 217 
samples (square brackets denote concentration). 200 μL of blood was immediately extracted 218 
from the lithium-heparin vacutainers and hemolysed in 200 μL of Triton X-100 solution (Triton 219 
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X-100, Amresco, Salon, OH) before blood [lactate] and [glucose] were measured (YSI 2300, 220 
Yellow Springs Instruments, Yellow Springs, OH). The remaining whole blood from each 221 
sample was centrifuged at 4000 rpm for 8 min at 4 ºC within 2 min of collection. Plasma was 222 
immediately extracted, frozen at -80 ºC and subsequently analyzed for [NO2-] using 223 
chemiluminescence, as previously described (68). 224 
Muscle biopsy 225 
Muscle samples were obtained from two incisions from the medial region of the m. vastus 226 
lateralis under local anesthesia (1% lidocaine) using the percutaneous Bergström needle biopsy 227 
technique with suction (4). Muscle samples were taken at three different time points before and 228 
following the intervention: at rest; following 3-min of severe-intensity exercise; and at task 229 
failure during severe-intensity exercise. The post-exercise biopsies were taken while subjects 230 
remained on the cycle ergometer and were typically collected within 10 s of the completion of 231 
the exercise bout.  Biopsy samples were immediately frozen in liquid nitrogen and stored at -232 
80 °C for subsequent analysis.  233 
Muscle metabolites 234 
Following a freeze-drying process, samples were dissected to remove visible blood, fat, and 235 
connective tissue. Approximately 2 mg aliquots of isolated muscle fibers were weighed on fine 236 
balance scales (Mettler Toledo XS105, Leicester, UK) and stored in 500 µL microcentrifuge 237 
tubes at -80 °C. Prior to metabolite analysis, 200 µL of 3 M perchloric acid was added to ~2 238 
mg dry weight (d.w.) muscle tissue. Following 3 min centrifugation and 30 min incubation on 239 
ice, 170 µL of supernatant was transferred to a fresh microcentrifuge tube and 255 µL of cooled 240 
2 M potassium bicarbonate (KHCO3) was added. This was centrifuged, and the supernatant 241 
analyzed for [PCr], [ATP] and [lactate] by fluorometric assays as previously described (39). 242 
Muscle glycogen and pH 243 
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Glycogen was extracted from ~2 mg d.w. muscle in 500 μL of 1 M hydrochloric acid (HCl) 244 
and hydrolyzed at 100 °C for 3 h to glycosyl units, which were measured using an automated 245 
glucose analyser (YSI 2300, Yellow Springs Instruments, Yellow Springs, OH) to determine 246 
muscle [glycogen]. Muscle pH was measured using a micro-pH meter (Sentron SI600, Roden, 247 
The Netherlands) following homogenization of ~1 mg d.w. muscle in 500 μL of a non-248 
buffering solution (145 mM KCl, 10 mM NaCl and 5 mM NaF). 249 
Muscle fiber type 250 
Approximately 20 mg of tissue obtained from each resting muscle biopsy sample was 251 
embedded in Tissue-Tek® O.T.C.™ compound  (Sakura Finetek Europe BV Zoeterwoude, 252 
The Netherlands), rapidly frozen in liquid nitrogen-cooled isopentane, and stored at -80 °C for 253 
subsequent histochemical analysis of myocellular characteristics. Serial cross sections (~10 μM 254 
thick) were cut in a cryostat (Cryostar NX50, Thermo Scientific, USA) maintained at -16 °C. 255 
Sections were mounted on 3 separate slides and pre-incubated at pH values of 4.3, 4.6 and 10.3. 256 
According to the lability to the acid and alkaline pre-incubation, the fibers were stained for 257 
myofibrillar ATPase, identified as type I, IIa, or IIx and counted under an Olympus CKX41 258 
microscope with cellSens Dimension software (Olympus Corporation, Tokyo, Japan).  259 
Data analysis procedures 260 
Oxygen uptake. The breath-by-breath V̇O2 data from each step exercise test were initially 261 
examined to exclude values lying more than four SDs from the local mean. The filtered data 262 
were subsequently linearly interpolated to provide second-by-second values and time-aligned 263 
to the start of exercise for each individual. The baseline V̇O2 was defined as the mean V̇O2 264 
measured over the final 60 s of the 3-min baseline period. The end-exercise V̇O2 was defined 265 
as the mean V̇O2 measured over the final 30 s of exercise. 266 
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PCr recovery kinetics. The acquired spectra were quantified using the jMRUI (version 3) 267 
software package employing the AMARES peak fitting algorithm as previously described (20, 268 
62). Using Prism 6 software (GraphPad Software Inc., La Jolla, CA, USA), the PCr recovery 269 
for each 24 s recovery period was fitted individually by a single exponential of the form  270 
PCr(t) = PCrend + PCr(0) (1 - e(-t/τ)) 271 
where PCrend is the end exercise PCr value, PCr(0) is the difference between PCrend and full 272 
recovery, t is the time from exercise cessation and τ is the time constant for the exponential 273 
recovery of PCr. A value of τ was calculated for each trial and then a mean determined from 274 
the four individual 24 s recovery periods. 275 
Statistical analyses 276 
Physiological and performance differences consequent to the interventions were assessed using 277 
analysis of covariance (ANCOVA) with baseline values used as a covariate. This approach was 278 
used to adjust for any small but potentially physiologically important chance imbalances at 279 
baseline (54). Significant effects were followed up by Fisher’s LSD post hoc tests. Data that 280 
were not normally distributed were log transformed before applying the ANCOVA. All values 281 
are reported as mean ± SD.  Statistical significance was accepted at P<0.05. 282 
Results 283 
Plasma [NO2-]  284 
Resting plasma [NO2-] was increased in SIT+BR (Pre: 39 ± 18 vs. Post: 257 ± 112 nM) and 285 
SIT+KNO3 (Pre: 75 ± 20 vs. Post: 310 ± 123 nM) compared to SIT (Pre: 45 ± 52 vs. Post: 55 286 
± 83 nM) (P<0.05). There was no difference in the change in resting plasma [NO2-] between 287 
SIT+BR and SIT+KNO3 (P>0.05). However, the change in plasma [NO2-] during severe-288 
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intensity cycling was greater at 3-min in SIT+BR (104 ± 92 nM reduction) compared to 289 
SIT+KNO3 (59 ± 108 nM reduction) (P<0.05; Fig. 1).  290 
Blood Pressure  291 
Systolic BP was reduced in SIT+BR compared to SIT (P<0.05) but not SIT+KNO3 (P>0.05; 292 
Table 1). The change in systolic BP in SIT was not different compared to SIT+KNO3 (P>0.05). 293 
Diastolic BP was reduced in SIT+BR compared to both SIT and SIT+KNO3 (P<0.05; Table 294 
1). There was no difference in diastolic BP between SIT and SIT+KNO3 (P>0.05). 295 
Incremental exercise test  296 
None of the interventions resulted in a significant change in body mass (SIT+BR: Pre: 80 ± 19 297 
kg, Post: 80 ± 19 kg; SIT+KNO3: Pre: 75 ± 13 kg, Post: 74 ± 13 kg; SIT: Pre: 78 ± 12 kg, Post: 298 
77 ± 11 kg; P>0.05). The V̇O2peak was increased to a greater extent in SIT+BR (11% increase) 299 
compared to both SIT (6% increase) and SIT+KNO3 (4% increase) (P<0.05; Table 1). There 300 
was no difference in the change in V̇O2peak between SIT and SIT+KNO3 (P>0.05). The increase 301 
in peak WR was not different between groups (P>0.05; Table 1).  302 
Step exercise tests 303 
The steady-state V̇O2 during moderate-intensity exercise was reduced in SIT+BR and 304 
SIT+KNO3 compared to SIT (P<0.05; Table 1). There was no difference in the extent of the 305 
reduction in steady-state V̇O2 between SIT+BR and SIT+KNO3 (P>0.05). There were no 306 
differences in baseline cycling V̇O2 between groups (P>0.05). 307 
The time to task failure during severe-intensity cycling was increased to a greater extent in 308 
SIT+BR (71% increase) compared to both SIT (47% increase) and SIT+KNO3 (42% increase) 309 
(P<0.05; Fig. 2). There was no difference in the change in time to task failure between SIT and 310 
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SIT+KNO3 (P>0.05). V̇O2peak attained during severe-intensity cycling was not different to that 311 
attained during incremental cycling. The change from pre- to post-intervention in blood 312 
[lactate] sampled at 1-min of severe-intensity cycling was significantly different in SIT+BR 313 
(Pre: 5.1 ± 1.4 vs. Post: 3.5 ± 0.8 mM) compared to SIT (Pre: 3.0 ± 1.4 vs. Post: 1.9 ± 0.9 mM) 314 
(P<0.05) but not SIT+KNO3 (Pre: 3.9 ± 1.7 vs. Post: 2.6 ± 0.7 mM) (P>0.05). There was no 315 
difference in blood [lactate] between SIT and SIT+KNO3 (P>0.05). Blood [glucose] measured 316 
during severe-intensity exercise was not different between groups (P>0.05). 317 
PCr recovery kinetics 318 
The reduction in muscle PCr recovery time constant following the cessation of 24 s high 319 
intensity knee-extension exercise was not different between groups (SIT: Pre: 31.6 ± 10.3 vs. 320 
Post: 24.7 ± 6.2 s; SIT+BR: Pre: 28.4 ± 4.9 vs. Post: 25.9 ± 3.5 s; SIT+KNO3: Pre: 31.7 ± 8.0 321 
vs. Post: 26.7 ± 7.3 s; P>0.05; Fig. 3).  322 
Muscle substrates and metabolites 323 
The concentrations of muscle ATP, PCr and glycogen, and muscle pH measured during severe-324 
intensity cycling were not different between groups (P>0.05; Table 2). However, muscle 325 
[lactate] was different between groups at 3-min of severe-intensity cycling (P<0.05; Table 2). 326 
Specifically, the accumulation of muscle lactate from rest to 3-min of severe-intensity cycling 327 
was reduced in SIT+BR compared to SIT+KNO3 (P<0.05; Table 2) but not SIT. 328 
Muscle fiber type 329 
There was no difference in the change in proportion of type I or type IIx muscle fibres between 330 
groups (P>0.05). However, the increase in the proportion of type IIa muscle fibers was greater 331 
in SIT and SIT+BR compared to SIT+KNO3 (P<0.05; Table 3).  332 
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Discussion 333 
The principal original finding of this study is that SIT with concurrent NO3- supplementation 334 
in the form of a natural dietary source (BR) results in superior physiological and exercise 335 
performance adaptations compared to both SIT alone and SIT with concurrent  336 
supplementation of a NO3- salt (KNO3). Specifically, SIT+BR enhanced time to task failure 337 
during severe-intensity cycling to a greater extent than SIT+KNO3 and SIT. Moreover, despite 338 
the administration of equimolar NO3- doses, SIT+BR resulted in a greater reduction in resting 339 
BP and a greater fall in plasma [NO2-] during exercise compared to SIT+KNO3. These findings 340 
suggest that BR, but not KNO3, supplementation may augment the improvements in exercise 341 
capacity and some physiological responses to SIT.  342 
Influence of SIT+BR and SIT+KNO3 on exercise capacity 343 
In the present study, peak work rate, V̇O2peak and the time to task failure during severe-intensity 344 
exercise were increased following the intervention period in all SIT groups. This confirms the 345 
efficacy of low volume, high-intensity interval training to increase exercise capacity (7, 24, 38, 346 
52). Interestingly, we found that V̇O2peak and time to task failure were increased to a greater 347 
extent when SIT was combined with BR compared to SIT alone. This is consistent with our 348 
previous study showing that 4 weeks SIT combined with BR improved V̇O2peak whereas SIT 349 
combined with NO3--depleted beetroot juice did not (59). Surprisingly, and in contrast to our 350 
previous study (59), the greater increase in VO2peak in SIT+BR was not accompanied by a 351 
significantly greater increase in peak WR during incremental exercise in the present study. 352 
However, although not significantly different, it is interesting to note that 7 out of 10 353 
participants in SIT+BR improved peak WR to a greater extent than the pooled group mean 354 
change (equivalent to an ~8% improvement), whereas fewer participants exhibited this trend 355 
in SIT (3/10) and SIT+KNO3 (2/10). 356 
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The greater improvement in V̇O2peak and time to task failure in SIT+BR might be explained by 357 
differences in muscle fiber type transformation and/or changes in muscle metabolic responses 358 
to exercise between groups. PGC-1α regulates the exercise-stimulated skeletal muscle 359 
remodelling from glycolytic type IIx to more oxidative type IIa and type I muscle fibers (36, 360 
47). The transcription of PGC-1α may be stimulated by both low volume SIT (37) and elevated 361 
NO bioavailability (42, 45, 46). It is therefore possible that, by activating common signalling 362 
pathways, dietary NO3- may augment some of the oxidative metabolic adaptations typical of 363 
exercise training. Consistent with this, Roberts et al. (51) have recently demonstrated that both 364 
exercise and NO3- increased the expression of PGC-1α in human and rat muscle. The change 365 
from type IIx towards type IIa and type I fibers typically associated with exercise training was 366 
observed in both the soleus (comprising ≤20% type IIa + IIx fibers (13)) and gastrocnemius 367 
(comprising ~100% type IIa + IIx fibers (13))) muscle of NO3- supplemented rats (51). In the 368 
present study, we found a significant increase in type IIa muscle fibers following the 369 
intervention period in SIT and SIT+BR but not SIT+KNO3. However, in contrast to recent 370 
findings in hypoxia (14) and normoxia (59), we did not find that concurrent dietary NO3- 371 
supplementation modulated muscle fiber type transformation compared to SIT alone. 372 
SIT+BR was associated with more favorable changes in blood and muscle markers of skeletal 373 
muscle metabolism during exercise following the intervention period. Specifically, blood 374 
lactate accumulation was reduced to a greater extent at 1-min severe-intensity exercise in 375 
SIT+BR compared to SIT and muscle lactate accumulation was reduced to a greater extent at 376 
3-min severe-intensity exercise in SIT+BR compared to SIT+KNO3. Dietary NO3- 377 
supplementation may reduce physiological strain during severe-intensity cycling by: 1) 378 
lowering the O2 cost of a given work rate within the severe-intensity domain (see below; 18); 379 
2) reducing the ATP and PCr cost of muscle force production (2, 20); 3) improving Ca2+ 380 
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handling in type II muscle fibers (29); and 4) improving blood flow distribution towards type 381 
II muscle and elevating the driving pressure for capillary-myocyte O2 flux (16, 17).  382 
Influence of SIT+BR and SIT+KNO3 on the O2 cost of exercise  383 
SIT alone had no effect on the O2 cost of exercise but submaximal V̇O2 was lowered post-384 
training in both SIT+BR and SIT+KNO3. This is consistent with several studies that have 385 
assessed steady-state V̇O2 after acute and short-term BR supplementation (3, 61, 70) and with 386 
two studies following 4 weeks NO3- supplementation (59, 70). The one other study that has 387 
assessed the effect of KNO3 supplementation on V̇O2 during exercise found that acute KNO3 388 
supplementation was ineffective at lowering the O2 cost of exercise in élite athletes (49). Fleuck 389 
et al. (18) previously reported that acute BR ingestion is more effective at reducing the O2 cost 390 
of exercise than an equimolar concentration of NO3- administered as NaNO3, perhaps due to 391 
differential effects on NO3-/NO2- metabolism and NO bioavailability evoked by the different 392 
vehicles of NO3- supplementation (See Effect of SIT+BR and SIT+KNO3 on markers of NO 393 
bioavailability below). However, in the present study, both SIT+BR and SIT+KNO3 reduced 394 
submaximal V̇O2 compared to SIT, with no difference in the magnitude of change between the 395 
two different types of NO3- supplementation.  396 
Influence of SIT+BR and SIT+KNO3 on markers of NO bioavailability  397 
Systolic and diastolic BP, and plasma [NO2-] were unchanged following 4 weeks of SIT. 398 
However, despite the administration of equimolar concentrations of NO3-, there were disparate 399 
effects of SIT+BR and SIT+KNO3 on BP. Resting plasma [NO2-] did not differ between the 400 
interventions in which dietary NO3- was administered as BR or as NO3- salt. However, greater 401 
reductions in BP were observed in SIT+BR compared to SIT+KNO3. Acute supplementation 402 
with KNO3 has been shown to lower systolic and diastolic BP (1, 32) but no previous study has 403 
compared the effects of chronic supplementation with KNO3 to BR. Our results are consistent 404 
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with Jonvik et al. (30) who reported that systolic and diastolic BP were reduced following BR 405 
but were unchanged following the same dose (~800 mg) of NO3- administered as a NaNO3-406 
containing beverage. Collectively, these results indicate that dietary NO3- consumed as BR is 407 
more effective at lowering BP than dietary NO3- consumed as a NO3- salt. This effect may be 408 
linked to the presence of other compounds within the BR beverage which may facilitate the 409 
conversion of NO2- into bioactive NO and other reactive nitrogen intermediates (21, 50). In 410 
this regard, it is pertinent that the relatively high total antioxidant content of BR (67) did not 411 
appear to blunt the adaptations to training in the present study. This is in contrast to previous 412 
studies in which high doses of vitamins C and E have been administered (43, 48). 413 
A possible greater effect of BR compared to KNO3 on NO synthesis may be particularly 414 
important during exercise to support NO-mediated physiological responses in contracting 415 
muscle. In this regard, it is interesting that, plasma [NO2-] declined to a greater extent during 416 
the severe-intensity exercise test in SIT+BR compared to SIT+KNO3 (Fig. 1), which is perhaps 417 
indicative of enhanced NO synthesis from NO2- during exercise in SIT+BR. Given the 418 
importance of NO2- availability to exercise performance (15), and evidence that the decline in 419 
plasma [NO2-] during exercise is correlated to improvements in performance (60, 69), 420 
differences in the magnitude of NO2- reduction may explain the superior improvements in 421 
exercise capacity observed in SIT+BR compared to SIT+KNO3 and SIT in the present study.  422 
We have previously reported that, in the absence of exercise training, exercise capacity 423 
improved following 15 days (61) and 28 days (59) of NO3- supplementation in the form of BR. 424 
However, it remains unclear whether similarly protracted periods of dietary NO3- 425 
supplementation in the form of a NO3- salt, could elicit comparable improvements in exercise 426 
performance. It is possible that different levels of exposure to NO bioavailability incurred by 427 
the different NO3--based supplements evoke discrete skeletal muscle adaptive responses which 428 
may have contributed to the differences in exercise capacity reported herein.  429 
20 
 
Influence of SIT+BR and SIT+KNO3 on oxidative capacity measured in vivo using 31P-MRS 430 
Elevating NO bioavailability via long term dietary NO3- administration may stimulate 431 
angiogenesis (22), mitochondrial biogenesis (45, 46) and the transformation towards a more 432 
oxidative skeletal muscle fiber type (47, 56), effects which may enhance muscle oxidative 433 
capacity. Owing to the equilibrium of the creatine kinase reaction, post-exercise muscle PCr 434 
resynthesis is a function of mitochondrial ATP production (53). Therefore, we measured the 435 
resynthesis of PCr following brief, high-intensity exercise, where the time constant for the 436 
exponential recovery of PCr is proportional to muscle mitochondrial oxidative capacity (10, 437 
41). In contrast to our hypothesis, 4 weeks of SIT combined with dietary NO3- supplementation 438 
in the form of either BR or KNO3 did not enhance muscle oxidative capacity to a greater extent 439 
than SIT alone. 440 
Mitochondrial oxidative capacity can also be estimated by measuring the activity of enzymes 441 
such as citrate synthase (12); markers that have been shown to be elevated following SIT (6, 8,  442 
25, 63). However, to our knowledge, this is the first study to demonstrate that 4 weeks SIT 443 
improved oxidative capacity in vivo using 31P-MRS. The reduction in the PCr recovery time 444 
constant in our study (~16%) was similar to that reported by Forbes et al. (19) in the recovery 445 
from moderate-intensity exercise following 2 weeks SIT. Mitochondrial biogenesis might be 446 
anticipated following exercise training (37, 38). Furthermore, interventions that elevate NO 447 
bioavailability such as dietary NO3- supplementation may also increase mitochondrial mass via 448 
comparable signaling pathways (42, 45, 46). However, in the present study, the effects of 449 
exercise training appear responsible for the speeding of PCr recovery observed in all SIT 450 
groups, with no additional benefit afforded by dietary NO3- supplementation.  451 
Experimental considerations 452 
21 
 
A key strength of the present investigation is that, in addition to comparing changes in 453 
exercise capacity between conditions, we assessed changes in markers of NO bioavailability, 454 
muscle metabolism (with biopsy) and oxidative capacity (using 31P-MRS techniques) to 455 
explore the mechanistic bases to any functional improvements observed. Furthermore, the 456 
inclusion of a SIT only control group allowed us to isolate the effects of SIT from the effects 457 
of dietary NO3- supplementation alongside SIT in the SIT+BR and SIT+KNO3 groups. In our 458 
study design, we elected to simulate the approach that athletes might adopt during training 459 
and in preparation for competition: that is, daily NO3- supplementation during training and 460 
then an acute NO3- dose prior to the criterion exercise trial. However, one disadvantage to 461 
this approach is that it complicates differentiation of the effects of training with NO3- 462 
supplementation, per se, from potential effects of acute NO3- supplementation on some of the 463 
physiological responses to exercise. For this reason, we cannot exclude the possibility that 464 
some of the physiological and exercise performance effects observed in the SIT+BR and 465 
SIT+KNO3 groups may have been influenced by the acute NO3- ingestion. Our results do, 466 
however, indicate that the combination of SIT+BR and acute BR ingestion results in superior 467 
physiological and performance outcomes compared to SIT alone or SIT+KNO3 and acute 468 
KNO3 ingestion. Further research is necessary to partition out the possible differences in the 469 
physiological adaptations to SIT alongside chronic NO3- supplementation with and without 470 
the addition of acute NO3- supplementation prior to post-training performance tests.   471 
The BR and KNO3- supplements were consumed by participants in this study as they might be 472 
used by athletes in training, i.e., no attempt was made to match the macronutrient, micronutrient 473 
or energy content of the supplements. Therefore, it is possible, though we believe unlikely, that 474 
the additional carbohydrate and/or energy intake provided by the BR supplement (~31g/day or 475 
~120 kcal/day) might have influenced, either positively or negatively, the adaptations to SIT 476 
compared to the other training groups. There was no change in body mass from pre-to post-477 
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training in any of the groups indicating that energy balance was maintained. It should also be 478 
acknowledged that, since the total work completed in each of the training programs was not 479 
quantified, it is unclear whether the enhanced adaptations in the SIT+BR group relative to the 480 
SIT and SIT+KNO3 groups were a result of a greater overall training load, due to an 481 
aggregation of acute ergogenic effects of BR, or to a greater physiological remodeling to the 482 
same training load.  483 
Summary 484 
The present study demonstrated that SIT combined with dietary NO3- supplementation in the 485 
form of BR improved exercise capacity to a greater extent than SIT alone and SIT combined 486 
with dietary NO3- supplementation in the form of KNO3. These findings may be linked to 487 
greater NO synthesis from NO2- or a greater increase in other bioactive nitroso compounds in 488 
SIT+BR compared to the other SIT groups. Increased dietary NO3- intake, including via 489 
supplementation with a natural NO3--rich product such as BR, may promote greater exercise 490 
capacity adaptations and NO-mediated physiological responses to exercise training. These 491 
findings might have important implications for augmenting some of the physiological and 492 
performance adaptations to a short-term SIT program.   493 
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Figure Legends 724 
Figure 1. Plasma [NO2-] declined to a greater extent from baseline to 3min during severe-725 
intensity exercise in SIT+BR (panel A) compared to SIT+KNO3 (panel B) (* P<0.05). Open 726 
circles represent plasma [NO2-] pre-intervention, closed circles represent plasma [NO2-] post-727 
intervention. Values presented as mean ± SE. 728 
Figure 2. Percentage increase in time to task failure and V̇O2peak during severe-intensity exercise 729 
in SIT (solid grey line), SIT+BR (solid black line) and SIT+KNO3 (dotted black line). Values 730 
presented as mean ± SE. The ANCOVA indicated the changes in time to task failure and 731 
V̇O2peak during severe-intensity exercise were greater in SIT+BR compared to SIT (# P<0.05) 732 
and compared to SIT+KNO3 (* P<0.05). 733 
Figure 3. Muscle phosphocreatine (PCr) time constant in the recovery from brief high-intensity 734 
exercise. The ANCOVA indicated that change in PCr recovery time constant with training was 735 
not different between groups (P>0.05).The dashed lines represent individual responses. The 736 
bars represent the mean response for each group (±SE).  737 
 738 
 739 
 740 
 741 
Table 1. Physiological and performance variables pre- and post-intervention.  
 SIT  SIT+BR  SIT+KNO3 
 Pre Post  Pre Post  Pre Post 
Blood pressure         
   SBP (mmHg) 114 ± 10 118 ± 8  119 ± 10 113 ± 10#  114 ± 11 112 ± 19 
   DBP (mmHg) 63 ± 8 65 ± 6  67 ± 10 63 ± 8#*  61 ± 8 64 ± 7 
Incremental test  
 
       
   Peak WR (W) 313 ± 62 335 ± 65  310 ± 97 335 ± 92  304 ± 62 324 ± 673 
   V̇O2 peak (L·min-1) 3.56 ± 0.81 3.76 ± 0.81  3.27 ± 1.11 3.62 ± 1.04#*  3.31 ± 0.81 3.45 ± 0.81 
 
 
Moderate-intensity exercise         
   End-exercise ?̇?O2 (L·min-1) 1.72 ± 0.41 1.77 ± 0.45  1.70 ± 0.41 1.64 ± 0.40#  1.56 ± 0.41 1.46 ± 0.33# 
Severe-intensity exercise         
    Time to task failure (s) 317 ± 88 467 ± 164  254 ± 55 434 ± 138#*  269 ± 67 383 ± 80 
         
 
Values are means ± SD. SBP, systolic blood pressure; DBP, diastolic blood pressure; V̇O2 peak, peak oxygen uptake; WR, work rate. # P<0.05 compared to change in SIT; 
* P<0.05 compared to change in SIT+KNO3. 
Table 2. Muscle metabolites and substrates during severe-intensity cycling exercise. Baseline values were used as a covariate in ANCOVA. Values 
presented as mean ± SD. * P<0.05 compared to change in SIT+KNO3.  
 SIT SIT+BR SIT+KNO3 
Pre Post Pre Post Pre Post 
Rest 3 min Ex Rest 3 min Ex Rest 3 min Ex Rest 3 min Ex Rest 3 min Ex Rest 3 min Ex 
[ATP]   
mmol∙kg d.w.-1 
28 ± 
11 
22 ± 
6 
22 ± 
4 
22 ± 
5 
21 ± 
6 
22 ± 
7 
22 ± 
8 
22 ± 
7 
21 ± 
13 
21 ± 
5 
20 ± 
3 
22 ± 
8 
26 ± 
14 
20 ± 
14 
21  ± 
11 
23 ± 
11 
16 ± 
7 
23 ± 
9 
[PCr]    
mmol∙kg d.w.-1 
77 ± 
16 
40 ± 
24 
32 ± 
10 
76 ± 
17 
44 ± 
17 
28 ± 
9 
69 ± 
13 
32 ± 
15 
30 ± 
13 
77 ± 
10 
41 ± 
17 
28 ± 
9 
57 ± 
14 
20 ± 
10 
17 ± 
9 
60 ± 
12 
18 ± 
3 
21 ± 
7 
[Glycogen] 
mmol∙kg d.w.-1 
354 ± 
83 
301 ± 
95 
239 ± 
92 
509 ± 
160 
407 ± 
117 
353 ± 
122 
416 ± 
109 
342 ± 
123 
214 ± 
88 
544 ± 
141 
458 ± 
140 
346 ± 
118 
379 ± 
131 
338 ± 
100 
270 ± 
33 
511 ± 
111 
405 ± 
120 
282 ± 
54 
[Lactate] 
mmol∙kg d.w.-1 
4 ± 3 43 ± 
22 
60 ± 
25 
5 ± 2 35 ± 
23 
63 ± 
35 
4 ± 3 53 ± 
35  
74 ± 
37 
5 ± 3 29 ± 
23 * 
66 ± 
29 
4 ± 2 77 ± 
56 
71 ± 
33 
4 ± 2 70 ± 
30 
68 ± 
37 
pH 7.4 ± 
0.2 
7.0 ± 
0.2 
6.9 ± 
0.2 
7.3 ± 
0.1 
7.1 ± 
0.2 
6.9 ± 
0.1 
7.3 ± 
0.3 
6.9 ± 
0.3 
6.8 ± 
0.2 
7.4 ± 
0.1 
7.1 ± 
0.2 
6.9 ± 
0.1 
7.3 ± 
0.2 
7.0 ± 
0.2  
6.8 ± 
0.1 
7.2 ± 
0.2 
7.1 ± 
0.1 
6.9 ± 
0.1 
 
Table 3. The effect of SIT with and without dietary NO3
- 
in the form of BR or KNO3 on muscle fibre type proprtions. Values presented 
as mean ± SD. * 
P<0.05 
compared to change in SIT+KNO3.  
 
 
 
 
 
 
 
 
 
 SIT SIT+BR SIT+KNO3 
  
Pre Post Pre Post Pre Post 
Type I (%) 53 ± 16 46 ± 15 57 ± 17 55 ± 13 55 ± 12 64 ± 14 
Type IIa (%) 40 ± 15 48 ± 19 * 36 ± 13 41 ± 9 * 42 ± 13 34 ± 14 
Type IIx (%)
 
7 ± 15 6 ± 11 7 ± 9 4 ± 6 3 ± 2 2 ± 2 



